These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 28758206)

  • 1. The Idiopathic Intracranial Hypertension Treatment Trial: A Review of the Outcomes.
    Smith SV; Friedman DI
    Headache; 2017 Sep; 57(8):1303-1310. PubMed ID: 28758206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Papilledema Outcomes from the Optical Coherence Tomography Substudy of the Idiopathic Intracranial Hypertension Treatment Trial.
    ;
    Ophthalmology; 2015 Sep; 122(9):1939-45.e2. PubMed ID: 26198807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial.
    ; Wall M; McDermott MP; Kieburtz KD; Corbett JJ; Feldon SE; Friedman DI; Katz DM; Keltner JL; Schron EB; Kupersmith MJ
    JAMA; 2014 Apr 23-30; 311(16):1641-51. PubMed ID: 24756514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Tolerability of Acetazolamide in the Idiopathic Intracranial Hypertension Treatment Trial.
    ten Hove MW; Friedman DI; Patel AD; Irrcher I; Wall M; McDermott MP;
    J Neuroophthalmol; 2016 Mar; 36(1):13-9. PubMed ID: 26587993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An update of idiopathic intracranial hypertension.
    Madriz Peralta G; Cestari DM
    Curr Opin Ophthalmol; 2018 Nov; 29(6):495-502. PubMed ID: 30169466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Relationship Between Optic Disc Volume, Area, and Frisén Score in Patients With Idiopathic Intracranial Hypertension.
    Sheils CR; Fischer WS; Hollar RA; Blanchard LM; Feldon SE;
    Am J Ophthalmol; 2018 Nov; 195():101-109. PubMed ID: 30081012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visual Field Outcomes for the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT).
    Wall M; Johnson CA; Cello KE; Zamba KD; McDermott MP; Keltner JL;
    Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):805-12. PubMed ID: 26934136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors Affecting Visual Field Outcomes in the Idiopathic Intracranial Hypertension Treatment Trial.
    Cello KE; Keltner JL; Johnson CA; Wall M;
    J Neuroophthalmol; 2016 Mar; 36(1):6-12. PubMed ID: 26618282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life at 6 months in the Idiopathic Intracranial Hypertension Treatment Trial.
    Bruce BB; Digre KB; McDermott MP; Schron EB; Wall M;
    Neurology; 2016 Nov; 87(18):1871-1877. PubMed ID: 27694262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric Intracranial Hypertension: a Current Literature Review.
    Aylward SC; Way AL
    Curr Pain Headache Rep; 2018 Feb; 22(2):14. PubMed ID: 29441432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optic disc haemorrhages at baseline as a risk factor for poor outcome in the Idiopathic Intracranial Hypertension Treatment Trial.
    Wall M; Thurtell MJ;
    Br J Ophthalmol; 2017 Sep; 101(9):1256-1260. PubMed ID: 28130349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudotumor cerebri: What We Have Learned from the Idiopathic Intracranial Hypertension Treatment Trial.
    Thakore RV; Johnson MA; Krohel GB; Johnson LN
    R I Med J (2013); 2016 May; 99(5):22-4. PubMed ID: 27128512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinal vessel diameter changes after 6 months of treatment in the Idiopathic Intracranial Hypertension Treatment Trial.
    Moss HE; Hollar RA; Fischer WS; Feldon SE
    Br J Ophthalmol; 2020 Oct; 104(10):1430-1434. PubMed ID: 31949093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric Intracranial Hypertension: A Spotlight on Imaging, the Idiopathic Intracranial Hypertension Treatment Trial, and COVID-19 Associated Cases.
    Brun BN; Aylward SC
    Semin Pediatr Neurol; 2021 Dec; 40():100922. PubMed ID: 34749916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Headache in Idiopathic Intracranial Hypertension: Findings From the Idiopathic Intracranial Hypertension Treatment Trial.
    Friedman DI; Quiros PA; Subramanian PS; Mejico LJ; Gao S; McDermott M; Wall M;
    Headache; 2017 Sep; 57(8):1195-1205. PubMed ID: 28752894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripapillary Retinal Pigment Epithelium Layer Shape Changes From Acetazolamide Treatment in the Idiopathic Intracranial Hypertension Treatment Trial.
    Wang JK; Kardon RH; Ledolter J; Sibony PA; Kupersmith MJ; Garvin MK;
    Invest Ophthalmol Vis Sci; 2017 May; 58(5):2554-2565. PubMed ID: 28492874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Longitudinal Idiopathic Intracranial Hypertension Trial: Outcomes From Months 6-12.
    Wall M; Kupersmith MJ; Thurtell MJ; Moss HE; Moss EA; Auinger P;
    Am J Ophthalmol; 2017 Apr; 176():102-107. PubMed ID: 28104417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetazolamide for the treatment of idiopathic intracranial hypertension.
    Supuran CT
    Expert Rev Neurother; 2015; 15(8):851-6. PubMed ID: 26154918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of vitamin A metabolism in IIH: Results from the idiopathic intracranial hypertension treatment trial.
    Libien J; Kupersmith MJ; Blaner W; McDermott MP; Gao S; Liu Y; Corbett J; Wall M;
    J Neurol Sci; 2017 Jan; 372():78-84. PubMed ID: 28017254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on Idiopathic Intracranial Hypertension.
    Wall M
    Neurol Clin; 2017 Feb; 35(1):45-57. PubMed ID: 27886895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.